188 related articles for article (PubMed ID: 29479896)
21. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
[TBL] [Abstract][Full Text] [Related]
22. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
23. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
24. High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
Choi GH; Kim GA; Choi J; Han S; Lim YS
Aliment Pharmacol Ther; 2019 Jul; 50(2):215-226. PubMed ID: 31135074
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Serum Alpha-Fetoprotein Level in Chronic Hepatitis C Patients.
Yang N; Li Z; Yan M; Xiao W; Zhang W; Long Y; Cheng Y; Ming K; Xu B
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775893
[TBL] [Abstract][Full Text] [Related]
26. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
27. Golgi protein 73(GP73), a useful serum marker in liver diseases.
Liu X; Wan X; Li Z; Lin C; Zhan Y; Lu X
Clin Chem Lab Med; 2011 Aug; 49(8):1311-1316. PubMed ID: 21663469
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.
Jin ZZ; Jin FF; Liu X; Liu N; Wen F; Lou JL
Braz J Infect Dis; 2019; 23(5):343-351. PubMed ID: 31542378
[TBL] [Abstract][Full Text] [Related]
29. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
30. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
[TBL] [Abstract][Full Text] [Related]
31. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
32. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
33. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
34. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Kim YI; Kim HS; Park JW
PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
[TBL] [Abstract][Full Text] [Related]
35. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.
Zeng DW; Liu YR; Dong J; Zhu YY; Li YB; Chen J; Zheng Q; Jiang JJ
Mol Med Rep; 2015 May; 11(5):3465-72. PubMed ID: 25592612
[TBL] [Abstract][Full Text] [Related]
36. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
Front Immunol; 2021; 12():775461. PubMed ID: 34899733
[TBL] [Abstract][Full Text] [Related]
37. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Kashala LO; Kalengayi MM; Essex M
Cancer Invest; 1992; 10(6):513-22. PubMed ID: 1384940
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Song T; Wang L; Xin R; Zhang L; Tian Y
J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
[TBL] [Abstract][Full Text] [Related]
39. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
40. A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.
Xiang Y; Chen P; Xia JR; Zhang LP
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
